Suchergebnisse - "Nozawa, Masahiro"

PubPharm (175)

1

Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan : A multicenter, retrospective, observational study (J-DART)

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2024

von Kato, T. | Nakano, Y. | Hongo, F. | +17

2

A case of neuroendocrine tumor at the external urethral meatus after total cystectomy

enthalten in: IJU case reports | 2023

von Miki, K. | Fujita, K. | Kuwahara, K. | +7

3

Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study) : 36-month follow-up results of a clinical chart review

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2023

von Yonese, J. | Hinata, N. | Masui, S. | +17

4

Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2023

von Blas, L. | Shiota, M. | Miyake, H. | +25

CommentIn: Int J Urol. 2023 Sep;30(9):796-797. - PMID 37563930

5

Prognosis of Patients Receiving Chemotherapy for Metastatic Upper Tract Urothelial Carcinoma Compared With Metastatic Urinary Bladder Cancer

enthalten in: Cancer diagnosis & prognosis | 2023

von Adomi, S. | Fujita, K. | Kita, H. | +13

6

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Shiota, M. | Miyake, H. | Takahashi, M. | +24

7

External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy

enthalten in: World journal of urology | 2023

von Minami, T. | Fujita, K. | Hashimoto, M. | +10

8

External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy

enthalten in: World journal of urology | 2023

von Minami, T. | Fujita, K. | Hashimoto, M. | +10

9

Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma : Japanese patients from the CLEAR study

enthalten in: Cancer medicine | 2023

von Eto, M. | Takagi, T. | Kimura, G. | +13

10

Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

enthalten in: International journal of clinical oncology | 2023

von Nakaigawa, N. | Tomita, Y. | Tamada, S. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]